 The goal of the investigation is to examine therapeutic monitoring of chemotherapy in castrate resistant prostate carcinoma with anti-3-18FFACBC in prostate carcinoma to determine if anti-3-18FFACBC amino acid imaging can serve as an accurate and efficient imaging biomarker. 